Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

A High Level of Soluble CD40L Is Associated with P. aeruginosa Infection in Patients with Cystic Fibrosis.

Bustamante AE, Jaime-Pérez JC, Cordero-Pérez P, Galindo-Rodríguez G, Muñoz-Espinosa LE, Villarreal-Villarreal CD, Mercado-Longoria R.

PLoS One. 2016 Dec 28;11(12):e0168819. doi: 10.1371/journal.pone.0168819. eCollection 2016.

2.

High-Dose Ibuprofen in Cystic Fibrosis.

Lands LC, Dauletbaev N.

Pharmaceuticals (Basel). 2010 Jul 13;3(7):2213-2224. Review.

3.

The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG.

Skurnik D, Cywes-Bentley C, Pier GB.

Expert Rev Vaccines. 2016 Aug;15(8):1041-53. doi: 10.1586/14760584.2016.1159135. Epub 2016 Mar 16.

PMID:
26918288
4.

Risk factors for the progression of cystic fibrosis lung disease throughout childhood.

Sanders DB, Li Z, Laxova A, Rock MJ, Levy H, Collins J, Ferec C, Farrell PM.

Ann Am Thorac Soc. 2014 Jan;11(1):63-72. doi: 10.1513/AnnalsATS.201309-303OC.

5.

Pseudomonas aeruginosa pyocyanin activates NRF2-ARE-mediated transcriptional response via the ROS-EGFR-PI3K-AKT/MEK-ERK MAP kinase signaling in pulmonary epithelial cells.

Xu Y, Duan C, Kuang Z, Hao Y, Jeffries JL, Lau GW.

PLoS One. 2013 Aug 27;8(8):e72528. doi: 10.1371/journal.pone.0072528. eCollection 2013.

6.

Pyocyanin-induced mucin production is associated with redox modification of FOXA2.

Hao Y, Kuang Z, Xu Y, Walling BE, Lau GW.

Respir Res. 2013 Aug 5;14:82. doi: 10.1186/1465-9921-14-82.

7.

The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis.

Sanders DB, Li Z, Rock MJ, Brody AS, Farrell PM.

Pediatr Pulmonol. 2012 Jun;47(6):567-73. doi: 10.1002/ppul.21621. Epub 2011 Dec 13.

8.

Regional differences in the evolution of lung disease in children with cystic fibrosis.

Li Z, Sanders DB, Rock MJ, Kosorok MR, Collins J, Green CG, Brody AS, Farrell PM.

Pediatr Pulmonol. 2012 Jul;47(7):635-40. doi: 10.1002/ppul.21604. Epub 2011 Dec 7.

9.

Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A.

Kuang Z, Hao Y, Walling BE, Jeffries JL, Ohman DE, Lau GW.

PLoS One. 2011;6(11):e27091. doi: 10.1371/journal.pone.0027091. Epub 2011 Nov 1.

10.

Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis.

Sanders DB, Li Z, Brody AS, Farrell PM.

Am J Respir Crit Care Med. 2011 Oct 1;184(7):816-21. doi: 10.1164/rccm.201105-0816OC.

11.

Cystic fibrosis: an-ion transport issue?

Pier G, Prince A, Cantin A.

Nat Med. 2011 Feb;17(2):166-7. doi: 10.1038/nm0211-166. No abstract available.

12.

Clinical significance of microbial infection and adaptation in cystic fibrosis.

Hauser AR, Jain M, Bar-Meir M, McColley SA.

Clin Microbiol Rev. 2011 Jan;24(1):29-70. doi: 10.1128/CMR.00036-10. Review.

13.

Relationships among health-related quality of life, pulmonary health, and newborn screening for cystic fibrosis.

Tluczek A, Becker T, Laxova A, Grieve A, Gilles CNR, Rock MJ, Gershan WM, Green CG, Farrell PM.

Chest. 2011 Jul;140(1):170-177. doi: 10.1378/chest.10-1504. Epub 2010 Nov 24.

Supplemental Content

Support Center